Total Funding
72
49
Total FundingSeed raised
Growth Score
-13 pts
Heat Score
-44 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
21883
Excalipoint Therapeutics develops targeted therapies that focus on modulating disease pathways at specific biological points.
About the Company
Excalipoint Therapeutics develops targeted therapies that focus on modulating disease pathways at specific biological points. The company applies research in molecular biology and drug discovery to design treatments for conditions with limited therapeutic options. Its work includes identifying precise intervention mechanisms and translating them
into clinical candidates through preclinical and clinical development processes. Excalipoint Therapeutics also collaborates with research and healthcare organizations to advance its pipeline and validate therapeutic approaches. The company integrates scientific data analysis and experimental methods to refine treatment strategies and support regulatory progression.
